08:59 AM EDT, 05/05/2025 (MT Newswires) -- Health care stocks declined pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) was 0.4% lower and the iShares Biotechnology ETF (IBB) was down 0.8% recently.

Teva Pharmaceutical (TEVA) and Alvotech ( ALVO ) said Selarsdi has been approved by the US Food and Drug Administration as interchangeable with the reference biologic Stelara. Shares of Teva were up over 5%, while Alvotech ( ALVO ) shares gained more than 2% premarket.